Published in Radiat Oncol on July 27, 2016
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Incidence trends in primary malignant penile cancer. Urol Oncol (2007) 1.90
Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control (2008) 1.89
Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys (2005) 1.12
Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev (2008) 1.12
Radiation therapy in the management of the primary penile tumor: an update. World J Urol (2008) 1.11
General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urol Int (2000) 1.09
Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys (2009) 1.07
Management of the lymph nodes in penile cancer. Urology (2010) 1.01
Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol (1995) 1.00
Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970-1979). Int J Radiat Oncol Biol Phys (1984) 0.97
Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol (1997) 0.95
Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol (2011) 0.94
High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results. Brachytherapy (2014) 0.94
Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol (2000) 0.89
American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy (2013) 0.89
The role of brachytherapy in organ preservation for penile cancer: A meta-analysis and review of the literature. Brachytherapy (2015) 0.86
Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy (2013) 0.86
Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys (1992) 0.86
Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy. Clin Oncol (R Coll Radiol) (2015) 0.82
Penile brachytherapy-Retrospective review of a single institution. Brachytherapy (2015) 0.82
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis. Radiat Oncol (2014) 0.80
Treatment of carcinoma of the penis by iridium 192 wire implant. Int J Radiat Oncol Biol Phys (1982) 0.79